Showing results (41-50 of 1,840) with videos related to
Sort By:
Pageof 184
Brain Research Bulletin|May 1, 1991
Prefrontal cortex alpha 2 adrenoceptors and energy balanceI S McGregor, J A Menéndez, D M Atrens, et al.Neuroscience|August 5, 2014
Regional Fos-expression induced by γ-hydroxybutyrate (GHB): comparison with γ-butyrolactone (GBL) and effects of co-administration of the GABAB antagonist SCH 50911 and putative GHB antagonist NCS-382P S van Nieuwenhuijzen, I S McGregor, M Chebib, et al.Neuroscience|February 10, 2007
High ambient temperature increases 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy")-induced Fos expression in a region-specific mannerG A Hargreaves, G E Hunt, J L Cornish, et al.Clinical Pharmacology and Therapeutics|March 18, 2015
Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawalD J Allsop, N Lintzeris, J Copeland, et al.Neuroscience|July 30, 1999
The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brainC P Stephenson, G E Hunt, A N Topple, et al.Brain, Behavior, and Immunity|September 25, 2013
A novel automated test battery reveals enduring behavioural alterations and cognitive impairments in survivors of murine pneumococcal meningitisL K Too, H J Ball, I S McGregor, et al.European Journal of Pharmacology|September 3, 1998
Effects of pre-exposure and co-administration of the cannabinoid receptor agonist CP 55,940 on behavioral sensitization to cocaineJ C Arnold, A N Topple, G E Hunt, et al.Australian Journal of Public Health|June 1, 1995
The public health significance of cannabis use in AustraliaW HallAustralian and New Zealand Journal of Public Health|February 1, 1996
Changes in the public perceptions of the health benefits of alcohol use, 1989 to 1994W HallPageof 184